| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |